Equity Profile

DVA

DaVita Inc.

Health CareHealth Care Services$12.3B

May5Tue

Post-Earnings Recap

ReportedQ1-2026After Close4:05 PM EDT

DaVita Inc. Beats on EPS, Stock Up 1.92%

Metric	Actual	Expected	Surprise
EPS	$2.87	$2.33	+19.09%
Revenue	N/A	$3.4B	N/A

management commentary, guidance changes, and full analysis available with Pro.

DaVita Inc. Beats on EPS, Stock Up 1.92%

Key Numbers

Metric	Actual	Expected	Surprise
EPS	$2.87	$2.33	+19.09%
Revenue	N/A	$3.4B	N/A

Management Commentary

Tone: Unknown

No transcript is on record, and the analysis is based on numerical results only.

What It Means

DaVita's strong EPS performance, exceeding expectations by over 19%, contributed to a positive stock reaction, with shares rising by 1.92%. However, the lack of revenue data and management commentary leaves some uncertainty about the overall performance and future outlook. Investors may be encouraged by the earnings beat but will be looking for more information in future reports.

Company Snapshot

DaVita Inc. is a leading provider of kidney care services in the healthcare sector, focusing on dialysis and related services for patients with chronic kidney disease....

Key Metrics to Watch

EPS

Earnings per share is a key indicator of profitability and will show how well DaVita is managing costs and revenues.

$2.33

Revenue

Total revenue gives insight into the company's growth and demand for its services, which is vital for assessing its market position.

$3.4B

Wall Street expectations, options signals, track record, and call prep available with Pro.

Original Pre-Earnings Preview

Context

Company Snapshot

DaVita Inc. is a leading provider of kidney care services in the healthcare sector, focusing on dialysis and related services for patients with chronic kidney disease. With a market cap of $10 billion, DaVita plays a crucial role in managing a significant health issue, making it an important player in the healthcare services industry.

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

75%

Avg EPS Surprise

+3.03%

Avg Stock Reaction

+0.92%

Last Quarter Recap

In Q4-2025, DaVita reported an EPS of $3.40, surpassing estimates by 5.07%. The stock reacted positively, gaining 1.69% the following day.

Management Promises & Guidance

Continue to enhance operational efficiencies.
Expand patient access to care services.
Focus on improving patient outcomes.

Expectations

Wall Street Expectations

Analysts expect DaVita to report solid earnings this quarter, with a consensus EPS of $2.33 and revenue of $3.4 billion. Investors will be keen to see if the company can maintain its growth trajectory amidst industry challenges.

Bull Case

If DaVita beats EPS estimates and shows strong revenue growth, it could signal robust demand for its services, leading to a positive stock reaction.

Bear Case

Conversely, if the company misses earnings expectations or shows signs of declining patient volumes, it could raise concerns about its future performance and negatively impact the stock.

Key Metrics to Watch

EPS

$2.33

Earnings per share is a key indicator of profitability and will show how well DaVita is managing costs and revenues.

Revenue

$3.4B

Total revenue gives insight into the company's growth and demand for its services, which is vital for assessing its market position.

Expectations

Two Questions That Matter

The print will turn on these two things.

Will DaVita's EPS exceed the consensus estimate of $2.33?

A beat on EPS would reinforce confidence in the company's profitability and operational efficiency.

How does DaVita plan to address any potential declines in patient volumes?

Understanding management's strategy for maintaining patient engagement is crucial for future revenue growth.

Edge

What the Street Is Missing

Why consensus could be wrong

The consensus may underestimate DaVita's ability to maintain patient volumes due to its strong operational efficiencies and patient care strategies.

Supporting Evidence

DaVita has a history of beating EPS estimates, with a 75% success rate over the last eight quarters.

The options market is pricing a significant move, indicating that investors expect volatility which could favor a positive surprise.

Key Risk

If DaVita's patient volumes show unexpected growth, it could significantly alter the earnings outlook.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

The upcoming earnings report is critical as it will reveal whether DaVita can sustain its growth amidst industry pressures.

Bull Confirmed If

An EPS above $2.33 with revenue exceeding $3.4 billion would confirm the bull case.

Bear Confirmed If

An EPS below $2.22 or revenue below $3.3 billion would confirm the bear case.

Pre-Earnings Positioning

Options Market

Implied Move

±11.04%

Historical Avg

±1.5%

Pricing rich

The options market is pricing in a significant move, suggesting that investors anticipate volatility around the earnings report.

Options are pricing ±10.5% while DVA has averaged ±1.5% over the last 8 prints — setup is pricing rich.

Detail

ATM IV

0.7%

30d HV

27.2%

Calls (85K)P/C Ratio: 0.20Puts (17K)

Edge

Historical Setup Match

Cross-company pattern from 30 similar setups.

Prior-quarter beat + options rich in Health Care

n=30

Fade rate: X of Y (Z%)

This setup has occurred 30 times across Health Care in the last 2 years. The average absolute 1-day move is 4.6%, with a raw directional average of +0.8% (modestly positive historical bias).

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If DaVita beats expectations, history suggests a positive stock reaction, averaging a +1.46% move.

In-Line / Cautious

If results are in line with expectations, the stock may react cautiously, reflecting uncertainty in future guidance.

Miss

A miss on earnings could lead to a decline, with history suggesting an average drop of -0.78%.

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Any updates on patient volume trends and how they are impacting revenue.
2Management's commentary on operational efficiencies and cost management.
3Insights into future growth strategies and market expansion plans.
4Details on any regulatory changes affecting the healthcare industry.
5Updates on patient outcomes and satisfaction metrics.

See the full picture

AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.

No charge today · Auto-bills $8/mo after 7 days · Cancel anytime

More Earnings This Week

5 Reports

May4

GRABReported

Grab Holdings Limited

RecapView

May4

GBDCReported

Company Snapshot

DaVita Inc. is a leading provider of kidney care services in the healthcare sector, focusing on dialysis and related services for patients with chronic kidney disease....

Key Metrics to Watch

EPS

Earnings per share is a key indicator of profitability and will show how well DaVita is managing costs and revenues.

$2.33

Revenue

Total revenue gives insight into the company's growth and demand for its services, which is vital for assessing its market position.

$3.4B

Wall Street expectations, options signals, track record, and call prep available with Pro.

Original Pre-Earnings Preview

Context

Company Snapshot

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

75%

Avg EPS Surprise

+3.03%

Avg Stock Reaction

+0.92%

Last Quarter Recap

In Q4-2025, DaVita reported an EPS of $3.40, surpassing estimates by 5.07%. The stock reacted positively, gaining 1.69% the following day.

Management Promises & Guidance

Continue to enhance operational efficiencies.
Expand patient access to care services.
Focus on improving patient outcomes.

Expectations

Wall Street Expectations

Bull Case

If DaVita beats EPS estimates and shows strong revenue growth, it could signal robust demand for its services, leading to a positive stock reaction.

Bear Case

Conversely, if the company misses earnings expectations or shows signs of declining patient volumes, it could raise concerns about its future performance and negatively impact the stock.

Key Metrics to Watch

EPS

$2.33

Earnings per share is a key indicator of profitability and will show how well DaVita is managing costs and revenues.

Revenue

$3.4B

Total revenue gives insight into the company's growth and demand for its services, which is vital for assessing its market position.

Expectations

Two Questions That Matter

The print will turn on these two things.

Will DaVita's EPS exceed the consensus estimate of $2.33?

A beat on EPS would reinforce confidence in the company's profitability and operational efficiency.

How does DaVita plan to address any potential declines in patient volumes?

Understanding management's strategy for maintaining patient engagement is crucial for future revenue growth.

Edge

What the Street Is Missing

Why consensus could be wrong

The consensus may underestimate DaVita's ability to maintain patient volumes due to its strong operational efficiencies and patient care strategies.

Supporting Evidence

DaVita has a history of beating EPS estimates, with a 75% success rate over the last eight quarters.

The options market is pricing a significant move, indicating that investors expect volatility which could favor a positive surprise.

Key Risk

If DaVita's patient volumes show unexpected growth, it could significantly alter the earnings outlook.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

The upcoming earnings report is critical as it will reveal whether DaVita can sustain its growth amidst industry pressures.

Bull Confirmed If

An EPS above $2.33 with revenue exceeding $3.4 billion would confirm the bull case.

Bear Confirmed If

An EPS below $2.22 or revenue below $3.3 billion would confirm the bear case.

Pre-Earnings Positioning

Options Market

Implied Move

±11.04%

Historical Avg

±1.5%

Pricing rich

The options market is pricing in a significant move, suggesting that investors anticipate volatility around the earnings report.

Options are pricing ±10.5% while DVA has averaged ±1.5% over the last 8 prints — setup is pricing rich.

Detail

ATM IV

0.7%

30d HV

27.2%

Calls (85K)P/C Ratio: 0.20Puts (17K)

Edge

Historical Setup Match

Cross-company pattern from 30 similar setups.

Prior-quarter beat + options rich in Health Care

n=30

Fade rate: X of Y (Z%)

This setup has occurred 30 times across Health Care in the last 2 years. The average absolute 1-day move is 4.6%, with a raw directional average of +0.8% (modestly positive historical bias).

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If DaVita beats expectations, history suggests a positive stock reaction, averaging a +1.46% move.

In-Line / Cautious

If results are in line with expectations, the stock may react cautiously, reflecting uncertainty in future guidance.

Miss

A miss on earnings could lead to a decline, with history suggesting an average drop of -0.78%.

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Any updates on patient volume trends and how they are impacting revenue.
2Management's commentary on operational efficiencies and cost management.
3Insights into future growth strategies and market expansion plans.
4Details on any regulatory changes affecting the healthcare industry.
5Updates on patient outcomes and satisfaction metrics.